Old Web
English
Sign In
Acemap
>
authorDetail
>
Tim Daynard
Tim Daynard
Protein kinase B
Integrin-linked kinase
Cancer research
Molecular biology
Angiogenesis
4
Papers
200
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model
2009
Breast Cancer Research
Jessica Kalra
Corinna Warburton
Karen Fang
Lincoln Edwards
Tim Daynard
Dawn Waterhouse
Wieslawa H. Dragowska
Brent W. Sutherland
Shoukat Dedhar
Karen A. Gelmon
Marcel B. Bally
Show All
Source
Cite
Save
Citations (55)
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of Integrin-linked kinase (ILK)
2008
Molecular Cancer Therapeutics
Lincoln A. Edwards
Janet Woo
Lynsey A. Huxham
Maite Verreault
Wieslawa H. Dragowska
Gigi N.C. Chiu
Ashish Rajput
Alastair H. Kyle
Jessica Kalra
Donald T. Yapp
Hong Yan
Andrew I. Minchinton
David Huntsman
Tim Daynard
Dawn Waterhouse
Brian Thiessen
Shoukat Dedhar
Marcel B. Bally
Show All
Source
Cite
Save
Citations (53)
Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth
2005
Oncogene
Lincoln A. Edwards
B. Thiessen
Wieslawa H. Dragowska
Tim Daynard
Marcel B. Bally
Shoukat Dedhar
Show All
Source
Cite
Save
Citations (92)
61 Mutant-PTEN leads to constitutive integrin-linked kinase (ILK) activity that regulates PKB/Akt activity in glioblastoma cancer cells and targeting ILK results in tumor growth-delay in vivo
2004
Ejc Supplements
Lincoln A. Edwards
Brian Thiessen
V. Dragowska
Tim Daynard
Shoukat Dedhar
Marcel B. Bally
Show All
Source
Cite
Save
Citations (0)
1
map